DionyMed Brands Inc. Signs Exclusive Distribution Agreement with Fruit Slabs

DionyMed Further Strengthens its Brand Portfolio with Premium Cannabis Edibles Brand in Northern California

TORONTO--(BUSINESS WIRE)-- DionyMed Brands Inc. (“DionyMed” or “Company”) (CSE:DYME; OTCQB:DYMEF), a multi-state cannabis brands, distribution and delivery platform, today announced an exclusive distribution agreement with California-based edibles brand, Fruit Slabs, to expand the Company’s cannabis brand portfolio in Central Valley and Northern California.

Fruit Slabs, California’s preeminent health and wellness edibles, which are designed for health conscious consumers, are all organic, gluten free, vegan, and Kosher. Each package of Fruit Slabs, which come in five flavors, is perfectly dosed into ten 10mg squares and assist in pain relief, sleep aid, anxiety relief and stimulate more energy. In addition to the brand’s acclaimed selection of real fruit ingredients, its newest product, Pride Passion, flavored with mango, passionfruit, lemon and lime, is now available.

“With more consumers focused on living a healthier lifestyle, Fruit Slabs provides consumers with a novel and delicious cannabis product that is organic, derived from natural ingredients and does not contain unnecessary sugars, fats or additives,” said Edward Fields, CEO of DionyMed. “By incorporating Fruit Slabs into the DionyMed Brands’ cannabis portfolio, we are expanding and diversifying our offerings to meet the distinct preferences of today’s cannabis consumers while delivering on our mission to provide healthy, trusted award-winning cannabis products.”

“As one of California’s leading distribution companies, DYME distribution was selected by Fruit Slabs as its strategic partner for wider and more comprehensive distribution in the Central Valley and Northern California regions,” added Roxanne Dennant, CEO at Fruit Slabs. “As the leading health and wellness edible brand in California, Fruit Slabs needed to make a partner choice that would match our level of professionalism and overall goals to be sold through as many licensed retailers as possible. DionyMed is the clear partner of choice when it comes to effectively reaching the high-growth California cannabis market through its direct-to-consumer delivery service platform Chill.”

To be added to the DionyMed e-mail distribution list, please e-mail DionyMed@kcsa.com with DionyMed in the subject line.

About DionyMed

Founded in 2017, DionyMed is a multi-state cannabis brands platform, supporting cultivators, manufacturers and award-winning brands in the medical and adult-use cannabis markets. DionyMed sells branded products in every category from flower to vape cartridges, concentrates and edibles. DionyMed serves cannabis consumers through retail dispensary distribution and direct-to-consumer fulfillment with its growing portfolio of award-winning brands. Learn more at dionymed.com and follow @DYME_Inc on Twitter and LinkedIn.

Forward-Looking Information and Statements

This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements, including but not limited to the risk factors set out in the Listing Statement of the Company available on the Company’s profile on SEDAR at www.sedar.com.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward- looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.

Edward Fields, CEO
Edward.Fields@DYME.com
669-232-5270

Peter Kampian, CFO
Peter.Kampian@DYME.com
647-948-8387

Investors:
Phil Carlson / Erika Kay
KCSA Strategic Communications
Phone: (212) 896-1233
Email: pcarlson@kcsa.com / ekay@kcsa.com

Media:
Kate Tumino / Brittany Tibaldi
KCSA Strategic Communications
212-896-1252 / 347-487-6794
ktumino@kcsa.com / btibaldi@kcsa.com

Source: DionyMed Brands Inc.